Revista de Medicina da UFC (Dec 2017)

Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management

  • Ricardo Evangelista Marrocos de Aragao,
  • Ieda Maria Alexandre Barreira,
  • Cristina Muccioli,
  • Francisco Holanda Oliveira Neto,
  • Barbara Lorena Alves Arrais,
  • Francisco George Magalhães de Oliveira,
  • Gustavo Jose Arruda Mendes Carneiro

DOI
https://doi.org/10.20513/2447-6595.2017v57n3p54-57
Journal volume & issue
Vol. 57, no. 3
pp. 54 – 57

Abstract

Read online

Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.

Keywords